Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C24H38N4O6S2 |
Molecular Weight | 542.712 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 2 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C\C=C1/NC(=O)[C@@H](CS)NC(=O)[C@H](NC(=O)C[C@H](OC(=O)[C@@H](NC1=O)C(C)C)\C=C\CCS)C(C)C
InChI
InChIKey=MEJLVLMAJJRLCR-GCCNXGTGSA-N
InChI=1S/C24H38N4O6S2/c1-6-16-21(30)28-20(14(4)5)24(33)34-15(9-7-8-10-35)11-18(29)27-19(13(2)3)23(32)26-17(12-36)22(31)25-16/h6-7,9,13-15,17,19-20,35-36H,8,10-12H2,1-5H3,(H,25,31)(H,26,32)(H,27,29)(H,28,30)/b9-7+,16-6-/t15-,17-,19-,20+/m1/s1
DescriptionSources: https://pubmed.ncbi.nlm.nih.gov/26331334
Sources: https://pubmed.ncbi.nlm.nih.gov/26331334
FR-135313 (also known as Romidepsin reduced) was studied as a selective inhibitor of the human histone deacetylase 1 (HDAC1).
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Q13547 Gene ID: 3065.0 Gene Symbol: HDAC1 Target Organism: Homo sapiens (Human) Sources: https://pubmed.ncbi.nlm.nih.gov/26331334 |
0.12 nM [IC50] |
Sample Use Guides
In Vitro Use Guide
Sources: https://pubmed.ncbi.nlm.nih.gov/26331334
Inhibition of recombinant human HDAC1 after 60 mins by fluorescence assay with IC50 = 0.00012 uM
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
390745-19-4
Created by
admin on Sat Dec 16 13:40:30 GMT 2023 , Edited by admin on Sat Dec 16 13:40:30 GMT 2023
|
PRIMARY | |||
|
9828788
Created by
admin on Sat Dec 16 13:40:30 GMT 2023 , Edited by admin on Sat Dec 16 13:40:30 GMT 2023
|
PRIMARY | |||
|
4MQ5UQAIB8
Created by
admin on Sat Dec 16 13:40:30 GMT 2023 , Edited by admin on Sat Dec 16 13:40:30 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
PRODRUG (METABOLITE ACTIVE)